Resultados: 2

    MRI fusion biopsy systems for diagnosing prostate cancer

    This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take this guidance fully into account, and specifically any special arrangements relating to the introduction of new inter...

    MRI-based technologies for assessing non-alcoholic fatty liver disease

    This guidance replaces the NICE medtech innovation briefing on LiverMultiScan for liver disease (MIB181). Your responsibility This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expecte...